Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

Supporting public health decision-making for Lyme disease: Assessing health outcomes, economic burden and intervention strategies using administrative data and decision-analytic models.

EF 2017-18

Résumé
Lyme disease (LD) is an increasingly common vector-borne disease reported in temperate climate zones in North America. The most common symptom of LD is erythema migrans (bull's-eye) rash. However, undetected or untreated LD can result in persistent functional, cardiac and neurological complications. In Ontario, LD incidence rates have increased 10-fold since 2006, with some areas reporting the highest rates in Canada (>21/100,000). Currently, consensus on the long-term outcomes and quality of life of LD patients is lacking. Additionally, the economic impact (healthcare costs) and the value of LD treatment and prevention strategies have not been assessed in Canada. For my first objective, I will conduct a systematic review focusing on long-term health outcomes, risk factors and quality of life associated with LD by assessing primary observational studies completed in North America and Europe. For my second objective, I will complete a costing study using health administrative data. I will use a population-based cohort study design to compare Ontario residents infected with laboratory-confirmed LD and uninfected individuals to determine the attributable healthcare costs of LD. Lastly, my third objective will provide economic evidence on the cost-effectiveness of current and potential LD treatment and prevention strategies (e.g. vaccination, personal protection, and antibiotic therapy) by assessing their cost per quality-adjusted life years gained from a healthcare payer perspective using a microsimulation model. Deeper understanding of long-term health outcomes can aid clinicians and patients with LD clinical management and educate the population at risk of LD. This work will also establish the value of potential LD intervention strategies and provide high-quality evidence to support health policy decision-making in Ontario.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
387254
Name
Mac Stephen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Supporting public health decision-making for Lyme disease: Assessing health outcomes, economic burden and intervention strategies using administrative data and decision-analytic models.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cost-Effectiveness Analysis; Costing Analysis; Decision Analysis And Simulation; Health Administrative Data; Infectious Diseases; Long-Term Sequelae; Lyme Disease; Quality Of Life; Systematic Review; Treatment And Prevention Strategies
Abstract
Lyme disease (LD) is an increasingly common vector-borne disease reported in temperate climate zones in North America. The most common symptom of LD is erythema migrans (bull's-eye) rash. However, undetected or untreated LD can result in persistent functional, cardiac and neurological complications. In Ontario, LD incidence rates have increased 10-fold since 2006, with some areas reporting the highest rates in Canada (>21/100,000). Currently, consensus on the long-term outcomes and quality of life of LD patients is lacking. Additionally, the economic impact (healthcare costs) and the value of LD treatment and prevention strategies have not been assessed in Canada. For my first objective, I will conduct a systematic review focusing on long-term health outcomes, risk factors and quality of life associated with LD by assessing primary observational studies completed in North America and Europe. For my second objective, I will complete a costing study using health administrative data. I will use a population-based cohort study design to compare Ontario residents infected with laboratory-confirmed LD and uninfected individuals to determine the attributable healthcare costs of LD. Lastly, my third objective will provide economic evidence on the cost-effectiveness of current and potential LD treatment and prevention strategies (e.g. vaccination, personal protection, and antibiotic therapy) by assessing their cost per quality-adjusted life years gained from a healthcare payer perspective using a microsimulation model. Deeper understanding of long-term health outcomes can aid clinicians and patients with LD clinical management and educate the population at risk of LD. This work will also establish the value of potential LD intervention strategies and provide high-quality evidence to support health policy decision-making in Ontario.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mac, Stephen
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~